Cancer Biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to.

  • Molecular Cancer Biomarkers
  • Tumor Suppressors Biomarkers
  • Predictive & Prognostic Biomarkers
  • Companion Biomarker

Related Conference of Cancer Biomarkers

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
September 19-20, 2024

7th World Heart and Brain Conference

London, UK
September 19-20, 2024

6th Annual Conference on Vascular Medicine

London, UK
October 17-18, 2024

8th Annual Heart Rhythm Conference

Barcelona, Spain
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in